Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Rodnitzky

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Annals of Neurology|September 1, 1992
Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degenerationZ K Wszolek, R F Pfeiffer, M H Bhatt, et al.
Acta Neuropathologica|March 21, 2002
Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonismZ K Wszolek, K Gwinn-Hardy, E K Wszolek, et al.
Neurology|October 26, 1999
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystoniaA Brashear, M F Lew, D D Dykstra, et al.
Neurology|September 26, 1997
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystoniaM F Lew, B T Adornato, D D Duane, et al.
Neurology|April 1, 1996
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's diseaseJ T Hutton, W C Koller, J E Ahlskog, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Annals of Neurology|September 1, 1992
Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degenerationZ K Wszolek, R F Pfeiffer, M H Bhatt, et al.
Acta Neuropathologica|March 21, 2002
Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonismZ K Wszolek, K Gwinn-Hardy, E K Wszolek, et al.
Neurology|October 26, 1999
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystoniaA Brashear, M F Lew, D D Dykstra, et al.
Neurology|September 26, 1997
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystoniaM F Lew, B T Adornato, D D Duane, et al.
Neurology|April 1, 1996
Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's diseaseJ T Hutton, W C Koller, J E Ahlskog, et al.
Pageof 4